285 related articles for article (PubMed ID: 32462938)
1. Persistent Infection Versus Type 2 Immunological Reaction in Lepromatous Leprosy.
Tanabe MB; Group AR; Rincon L; Stryjewska BM; Sarria JC
J Investig Med High Impact Case Rep; 2020; 8():2324709620927884. PubMed ID: 32462938
[TBL] [Abstract][Full Text] [Related]
2. Recognizing and managing the immunologic reactions in leprosy.
Kamath S; Vaccaro SA; Rea TH; Ochoa MT
J Am Acad Dermatol; 2014 Oct; 71(4):795-803. PubMed ID: 24767732
[TBL] [Abstract][Full Text] [Related]
3. [Leprosy and the testis].
Rodríguez G; Abaúnza MC; Vargas EJ; López F
Biomedica; 2012; 32(1):13-22. PubMed ID: 23235783
[TBL] [Abstract][Full Text] [Related]
4. [Histoid leprosy with erythema nodosum leprosum].
Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
[TBL] [Abstract][Full Text] [Related]
5. Histopathology of the lepromatous skin biopsy.
Massone C; Belachew WA; Schettini A
Clin Dermatol; 2015; 33(1):38-45. PubMed ID: 25432809
[TBL] [Abstract][Full Text] [Related]
6. Concomitant lucio phenomenon and erythema nodosum in a leprosy patient: clues for their distinct pathogeneses.
Benard G; Sakai-Valente NY; Bianconcini Trindade MA
Am J Dermatopathol; 2009 May; 31(3):288-92. PubMed ID: 19384072
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide in the treatment of leprosy.
Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
[TBL] [Abstract][Full Text] [Related]
8. Clinico-pathological features of erythema nodosum leprosum: A case-control study at ALERT hospital, Ethiopia.
Negera E; Walker SL; Girma S; Doni SN; Tsegaye D; Lambert SM; Idriss MH; Tsegay Y; Dockrell HM; Aseffa A; Lockwood DN
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006011. PubMed ID: 29028793
[TBL] [Abstract][Full Text] [Related]
9. Histoid leprosy with erythema nodosum leprosum--a case report.
Vasavi S; Reddy BS
Indian J Lepr; 2012; 84(1):27-9. PubMed ID: 23077781
[TBL] [Abstract][Full Text] [Related]
10. Erythema nodosum leprosum associated with minocycline.
Travassos AR; Antunes J; Pacheco D; Almeida LS; Filipe P; Marques MS
Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(2):39-41. PubMed ID: 23000940
[TBL] [Abstract][Full Text] [Related]
11. [Bullous erythema nodosum leprosum. A case report in French Guiana].
Couppié P; Sainte-Marie D; About V; Heid E; Pradinaud R
Ann Dermatol Venereol; 1998 Mar; 125(3):188-90. PubMed ID: 9747246
[TBL] [Abstract][Full Text] [Related]
12. Localized and persistent erythema nodosum leprosum - a rare variant?
Prabhu S; Rao R; Sripathi H; Rao L; Singh R
Dermatol Online J; 2008 Mar; 14(3):16. PubMed ID: 18627717
[TBL] [Abstract][Full Text] [Related]
13. Bullous erythema nodosum leprosum manifesting in the post partum period with unusual features.
Verma R; Vasudevan B; Pragasam V; Moorchung N; Mitra D; Gopal M
Lepr Rev; 2015 Mar; 86(1):96-101. PubMed ID: 26065152
[TBL] [Abstract][Full Text] [Related]
14. Lepromatous leprosy presenting with type II reaction before and type I reaction after treatment.
Robati RM; Mozafari N; Bidari-Zerehpoosh F; Niknejad N; Bizaval Z
Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054941
[TBL] [Abstract][Full Text] [Related]
15. Reactive perforating leprosy: pustular erythema nodosum leprosum with epidermal perforation and liberation of Mycobacterium leprae.
Ghorpade A
Int J Dermatol; 2014 Feb; 53(2):221-3. PubMed ID: 24319988
[No Abstract] [Full Text] [Related]
16. [Erythema nodosum leprosum case series report: clinical profile, immunological basis and treatment implemented in health services].
Guerra JG; Penna GO; Castro LC; Martelli CM; Stefani MM; Costa MB
Rev Soc Bras Med Trop; 2004; 37(5):384-90. PubMed ID: 15361954
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.
Schmitz V; Prata RB; Barbosa MG; Mendes MA; Brandão SS; Amadeu TP; Rodrigues LS; Ferreira H; Costa Fda M; Dos Santos JB; Pacheco Fdos S; Machado Ade M; Nery JA; Hacker Mde A; Sales AM; Pinheiro RO; Sarno EN
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004955. PubMed ID: 27556927
[TBL] [Abstract][Full Text] [Related]
18. [Patient with Hansen disease and lepromatous reaction with predominant neural involvement].
Gálvez J; López-Domínguez JM; Navarro A; Creagh R; Casado JL; Chinchón Lara I
Neurologia; 1998 Jan; 13(1):41-4. PubMed ID: 9522583
[TBL] [Abstract][Full Text] [Related]
19. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
Naafs B
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120
[No Abstract] [Full Text] [Related]
20. Clinical, immunological and histological aspects of an uncommon type II reaction in patients with lepromatous leprosy.
Esquenazi D; Moreira AL; Miranda A; Nery JA; Alvarenga FF; Sarno EN; Pereira GM
Clin Exp Dermatol; 2008 May; 33(3):294-7. PubMed ID: 18261142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
